RxDoctor Payments Data

Saundra Brennan

Medical · Omaha, NENPI 1154427037

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,294 of the $6,460 with a category attached, or 82.0%. It is spread thinly across 26 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,766, 3.0 times the $582 reported in 2021. Among medical clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,460in general payments, 2019–2025

Across 307 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$1K
  • Lilly USA, LLC$763
  • UCB, Inc.$459
  • Incyte Corporation$412
  • AbbVie$384
  • Mayne Pharma Commercial LLC$347
  • plus $3K from 20 others

What the payments were for

  • Consulting fees$92314%
  • Food & beverage$5,29482%
  • Education$2434%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,460 in reported general payments places this provider in the 90th percentile of 216 medical providers in Nebraska.

See all medical providers in Nebraska

Medicare billing

Part B allowed, 2024
$100,443
Medicare patients
574
Services billed
2,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab11$74,852
Clobetasol Propionate70$3,917
Ketoconazole80$1,639
Fluorouracil18$1,535
Metronidazole18$778
Minocycline Hcl40$689
MethotrexateMethotrexate Sodium67$673
Triamcinolone Acetonide97$594
Mometasone Furoate29$463
Cefdinir18$393
Cephalexin35$386
Doxycycline Hyclate14$261
Mupirocin29$222
Hydrocortisone47$202
Gabapentin15$186

Paid to pharmacies, not to this prescriber.

Other medical in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →